SCHEMBL20518698

SCHEMBL20518698

NNC(=O)Cn1nnc(CC(=O)O)n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.44
ATM Q13315 2/20 0.44
HSD17B10 Q99714 1/20 0.44
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 3/20 0.40
CNR2 P34972 2/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 2/20 0.36
KDM6B O15054 1/20 0.36
KDM4A O75164 1/20 0.36
KDM5A P29375 1/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
KDM5C P41229 1/20 0.33
PHF8 Q9UPP1 1/20 0.33
KDM2A Q9Y2K7 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18839794 0.87 PKM (0.44) PKMATMHSD17B10ALDH1A1KDM4E
SCHEMBL18839792 0.79 USP2 (0.40) PKMATMHSD17B10ALDH1A1KDM4E
SCHEMBL20518595 0.77 PKM (0.38) PKMATMHSD17B10ALDH1A1KDM4E
SCHEMBL14966908 0.76 ATM (0.50) PKMATMALDH1A1KDM4EPOLB
SCHEMBL20518665 0.76 PKM (0.37) PKMATMHSD17B10ALDH1A1KDM4E
SCHEMBL18839753 0.75 KDM4E (0.39) PKMATMHSD17B10ALDH1A1KDM4E
SCHEMBL18839851 0.75 PKM (0.47) PKMATMHSD17B10ALDH1A1CNR2
SCHEMBL18839682 0.73 KDM4E (0.41) PKMATMHSD17B10ALDH1A1KDM4E
SCHEMBL18839834 0.72 ALDH1A1 (0.38) PKMATMHSD17B10ALDH1A1KDM4E
SCHEMBL8215669 0.72 HPGD (0.70) PKMALDH1A1KDM4EPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180282331-A1 7-Oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections (changed by PCT to: 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS WOCKHARDT LIMITED (IN) 2018-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180282331-A1 7-Oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections (changed by PCT to: 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS TST, THPO, STS PKM 3431/4885ATM 2354/4885HSD17B10 1728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.